507 related articles for article (PubMed ID: 25733311)
21. Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations.
Ngan CL; Asmawi AA
Drug Deliv Transl Res; 2018 Oct; 8(5):1527-1544. PubMed ID: 29881970
[TBL] [Abstract][Full Text] [Related]
22. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment.
Neupane YR; Srivastava M; Ahmad N; Kumar N; Bhatnagar A; Kohli K
Int J Pharm; 2014 Dec; 477(1-2):601-12. PubMed ID: 25445972
[TBL] [Abstract][Full Text] [Related]
23. Lipid nanoparticles as drug/gene delivery systems to the retina.
del Pozo-Rodríguez A; Delgado D; Gascón AR; Solinís MÁ
J Ocul Pharmacol Ther; 2013 Mar; 29(2):173-88. PubMed ID: 23286300
[TBL] [Abstract][Full Text] [Related]
24. The significance of drug-to-lipid ratio to the development of optimized liposomal formulation.
Chountoulesi M; Naziris N; Pippa N; Demetzos C
J Liposome Res; 2018 Sep; 28(3):249-258. PubMed ID: 28627268
[TBL] [Abstract][Full Text] [Related]
25. Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy.
Zucker D; Andriyanov AV; Steiner A; Raviv U; Barenholz Y
J Control Release; 2012 Jun; 160(2):281-9. PubMed ID: 22019556
[TBL] [Abstract][Full Text] [Related]
26. Conjugated oligomer-based fluorescent nanoparticles as functional nanocarriers for nucleic acids delivery.
Wang X; He F; Li L; Wang H; Yan R; Li L
ACS Appl Mater Interfaces; 2013 Jun; 5(12):5700-8. PubMed ID: 23721201
[TBL] [Abstract][Full Text] [Related]
27. Lipids and their derivatives: by-products used as essential building blocks for modern drug delivery systems.
Tu Y; Zhu L
Curr Drug Targets; 2014 May; 15(5):502-17. PubMed ID: 24597533
[TBL] [Abstract][Full Text] [Related]
28. Lipid nanocarriers for microRNA delivery.
Scheideler M; Vidakovic I; Prassl R
Chem Phys Lipids; 2020 Jan; 226():104837. PubMed ID: 31689410
[TBL] [Abstract][Full Text] [Related]
29. Bioconjugate Therapeutics: Current Progress and Future Perspective.
Li F; Mahato RI
Mol Pharm; 2017 May; 14(5):1321-1324. PubMed ID: 28457140
[No Abstract] [Full Text] [Related]
30. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
Girotra P; Singh SK
AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007
[TBL] [Abstract][Full Text] [Related]
31. "Clicking" Gene Therapeutics: A Successful Union of Chemistry and Biomedicine for New Solutions.
Astakhova K; Ray R; Taskova M; Uhd J; Carstens A; Morris K
Mol Pharm; 2018 Aug; 15(8):2892-2899. PubMed ID: 29300491
[TBL] [Abstract][Full Text] [Related]
32. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release.
Souza LG; Silva EJ; Martins AL; Mota MF; Braga RC; Lima EM; Valadares MC; Taveira SF; Marreto RN
Eur J Pharm Biopharm; 2011 Sep; 79(1):189-96. PubMed ID: 21352915
[TBL] [Abstract][Full Text] [Related]
33. Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies.
Li J; Guo X; Liu Z; Okeke CI; Li N; Zhao H; Aggrey MO; Pan W; Wu T
Drug Dev Ind Pharm; 2014 Jul; 40(7):980-7. PubMed ID: 23662696
[TBL] [Abstract][Full Text] [Related]
34. Recent Strategies in Resveratrol Delivery Systems.
Machado ND; Fernández MA; Díaz DD
Chempluschem; 2019 Jul; 84(7):951-973. PubMed ID: 31943987
[TBL] [Abstract][Full Text] [Related]
35. Liposomes in biology and medicine.
Schwendener RA
Adv Exp Med Biol; 2007; 620():117-28. PubMed ID: 18217339
[TBL] [Abstract][Full Text] [Related]
36. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.
Simovic S; Barnes TJ; Tan A; Prestidge CA
Nanoscale; 2012 Feb; 4(4):1220-30. PubMed ID: 22159191
[TBL] [Abstract][Full Text] [Related]
37. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
38. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
39. Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility.
Durán-Lobato M; Martín-Banderas L; Lopes R; Gonçalves LM; Fernández-Arévalo M; Almeida AJ
Drug Dev Ind Pharm; 2016; 42(2):190-8. PubMed ID: 25996463
[TBL] [Abstract][Full Text] [Related]
40. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne.
Jain A; Garg NK; Jain A; Kesharwani P; Jain AK; Nirbhavane P; Tyagi RK
Drug Dev Ind Pharm; 2016; 42(6):897-905. PubMed ID: 26577703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
